Aug 12, 2020
Australian Therapeutic Goods Administration Approves the First Phase I Trial of ATG-017 for the Treatment of Patients with Advanced Solid Tumors and Hematological Malignancies
Jun 02, 2020
Moleculin Announces Emory University Clinical Trial of WP1066 Begins Enrollment
Apr 01, 2020
Dr. Roeland Nusse: Gairdner Award Recipient and Bio-Techne Board of Directors Member
Mar 24, 2020
Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted
Mar 19, 2020
Glucagon Receptor Structures Reveal G protein Specificity Mechanism
Mar 12, 2020
C-X-C Chemokine Receptor (CXCR) Inhibitors Market & Pipeline Insights, 2020 - Key Emerging Drugs (X4 Pharmaceutical's X4P-001 and Others) are Going to Be Blockbusters in the Coming Years
Feb 04, 2020
Kungl. Vetenskapsakademien: Sjöberg Prize Awarded for Decisive Discoveries About Cell Growth
Jan 07, 2020
Revolution Medicines to Present Preliminary Data from Phase 1 Clinical Trial of RMC-4630 at 6th AACR-IASLC International Joint Conference
Jan 02, 2020
Arena Pharmaceuticals and Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory Targets
Dec 17, 2019
Kanazawa University Research: Possible Strategy for Cancer Treatment Found in Nuclear Transport Proteins
Dec 10, 2019
Caris Life Sciences to Present Data Evaluating PI3K Pathway Alterations at the 2019 San Antonio Breast Cancer Symposium (SABCS)
Nov 06, 2019
Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364
Oct 07, 2019
Kinesis Monetary System Appoints Shane Morand to Advisory Board
Oct 02, 2019
Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening
Sep 23, 2019
ESMO Annual Meeting 2019: Menarini Ricerche Presents the Preclinical Characterization of MEN1611, a Novel PI3K Inhibitor in Development for the Treatment of Breast Cancer
Aug 27, 2019
AntlerA Leverages Precision-engineered Protein Therapeutic Platform to Harness Body's Regenerative Potential
Aug 13, 2019
Researchers Study Ancestors of Proteins to Understand Their Role in Growth
Jul 23, 2019
The PI3K inhibitors market is forescasted to grow at a CAGR of about 5% during the forecast period
Jul 17, 2019
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38a Kinase Inhibitor Neflamapimod on the Neurodegenerative Process
Jul 08, 2019
ArcherDX and Ayala Pharmaceuticals Announce Strategic Companion Diagnostic Collaboration